Isolated tumor cells in esophageal cancer: Implications for the surgeon and the pathologist

Annals of Surgery

Volumn 252, Issue 2, 2010, Pages 299-306

  Thompson, Sarah K ^a   Ruszkiewicz, Andrew R ^b   Jamieson, Glyn G ^a   Sullivan, Thomas R ^c   Devitt, Peter G ^a  

^a ROYAL ADELAIDE HOSPITAL   (Australia)

^b Division of Tissue Pathology   (Australia)

^c UNIVERSITY OF ADELAIDE   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

CISPLATIN; FLUOROURACIL;

ADJUVANT THERAPY; ADULT; AGED; ARTICLE; CANCER ADJUVANT THERAPY; CANCER RADIOTHERAPY; CONTINUOUS INFUSION; ESOPHAGEAL ADENOCARCINOMA; ESOPHAGUS CANCER; ESOPHAGUS RESECTION; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LYMPH NODE; LYMPH NODE DISSECTION; MAJOR CLINICAL STUDY; MALE; MICROMETASTASIS; MULTIPLE CYCLE TREATMENT; PATHOLOGIST; PRIORITY JOURNAL; SQUAMOUS CELL CARCINOMA; SURGEON; SURVIVAL RATE; TUMOR CELL;

ESOPHAGEAL NEOPLASMS; ESOPHAGECTOMY; FEMALE; HUMANS; IMMUNOENZYME TECHNIQUES; LYMPH NODES; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; NEOPLASM STAGING; PROGNOSIS; PROPORTIONAL HAZARDS MODELS; REGISTRIES; STAINING AND LABELING; STATISTICS, NONPARAMETRIC; SURVIVAL RATE;

EID: 77955170876     PISSN: 00034932     EISSN: 15281140     Source Type: Journal    
DOI: 10.1097/SLA.0b013e3181e61e15     Document Type: Article

References (50)

1. Xi L, Luketich JD, Raja S, et al. Molecular staging of lymph nodes from patients with esophageal adenocarcinoma. Clin Cancer Res. 2005;11:1099-1109. (Pubitemid 40175759)
2. McGuill MJ, Byrne P, Ravi N, et al. The prognostic impact of occult lymph node metastasis in cancer of the esophagus or esophagogastric junction: systematic review and meta-analysis. Dis Esophagus. 2008;21:236-240.
3. Scheuemann P, Hosch SB, Izbicki JR. Cytokeratins and other sensitive markers for esophageal cancer and metastases. Dis Esophagus. 2001;14:85-90.
4. Bonavina L, Ferrero S, Midolo V, et al. Lymph node micrometastases in patients with adenocarcinoma of the esophagogastric junction. J Gastrointest Surg. 1999;3:468-476.
5. Heeren PA, Kelder W, Blondeel I, et al. Prognostic value of nodal microme-tastases in patients with cancer of the gastro-esophageal junction. Eur J Surg Oncol. 2005;31:270-276.
6. Komukai S, Nishimaki T, Watanabe H, et al. Significance of immunohisto-chemically demonstrated micrometastases to lymph nodes in esophageal cancer with histologically negative nodes. Surgery. 2000;127:40-46.
7. Doki Y, Ishikawa O, Mano M, et al. Cytokeratin deposits in lymph nodes show distinct clinical significance from lymph node micrometastasis in human esophageal cancers. J Surg Res. 2002;107:75-81.
8. Mueller JD, Stein HJ, Oyang T, et al. Frequency and clinical impact of lymph node micrometastasis and tumor cell microinvolvement in patients with adenocarcinoma of the esophagogastric junction. Cancer. 2000;89:1874-1882.
9. Schurr PG, Yekebas EF, Kaifi JT, et al. Lymphatic spread and microinvolve-ment in adenocarcinoma of the esophagogastric junction. J Surg Oncol. 2006;94:307-315.
10. Izbicki JR, Hosch SB, Pichlmeier U, et al. Prognostic value of immunohis-tochemically identifiable tumor cells in lymph nodes of patients with completely resected esophageal cancer. N Engl J Med. 1997;337:1188-1194.
11. MacGuill MJ, Barrett C, Ravi N, et al. Isolated tumour cells in pathological node-negative lymph nodes adversely affect prognosis in cancer of the oesophagus or oesophagogastric junction. J Clin Pathol. 2007;60:1108-1111.
12. Koenig AM, Prenzel KL, Bogoevski D, et al. Strong impact of micrometa-static tumor cell load in patients with esophageal carcinoma. Ann Surg Oncol. 2009;16:454-462.
13. Natsugoe S, Mueller J, Stein HJ, et al. Micrometastasis and tumor cell microinvolvement of lymph nodes from esophageal squamous cell carcinoma. Cancer. 1998;83:858-866.
14. Yekebas EF, Schurr PG, Kaifi JT, et al. Effectiveness of radical en-bloc-esophagectomy compared to transhiatal esophagectomy in squamous cell cancer of the esophagus is influenced by nodal micrometastases. J Surg Oncol. 2006;93:541-549.
15. Glickman JN, Torres C, Wang HH, et al. The prognostic significance of lymph node micrometastases in patients with esophageal cancer. Cancer. 1999;85:769-778.
16. Vazquez-Sequeiros E, Wang L, Burgart L, et al. Occult lymph node metas-tases as a predictor of tumor relapse in patients with node-negative esopha-geal carcinoma. Gastroenterology. 2002;122:1815-1821.
17. Waterman TA, Hagen JA, Peters JH, et al. The prognostic importance of immunohistochemically detected node metastases in resected esophageal adenocarcinoma. Ann Thorac Surg. 2004;78:1161-1169.
18. Zingg U, Montani M, Busch M, et al. Prognostic influence of immunohisto-chemically detected lymph node micrometastasis and histological subtype in pN0 oesophageal cancer. Eur J Surg Oncol. 2009;35:593-599.
19. Sato F, Shimada Y, Li Z, et al. Lymph node micrometastasis and prognosis in patients with oesophageal squamous cell carcinoma. Br J Surg. 2001;88: 426-432.
20. Aly A, Jamieson GG, Pyragius M, et al. Antireflux anastamosis following oesophagectomy. ANZ J Surg. 2004;74:434-438.
21. Jamieson GG, Lamb PJ, Thompson SK. The role of lymphadenectomy in esophageal cancer. Ann Surg. 2009;250:206-209.
22. Thompson SK, Ruszkiewicz AR, Jamieson GG, et al. Improving the accuracy of TNM staging in esophageal cancer: a pathological review of resected specimens. Ann Surg Oncol. 2008;15:3447-3458.
23. Zhou ZW, Rieger N, Ruszkiewicz A, et al. Detection of lymph nodes micrometastases in Dukes' A and B colorectal cancer using anti-cytokeratin antibodies AE1/AE3. World J Gastroenterol. 2005;11:3640-3643.
24. Hermanek P, Hutter RV, Sobin LH, et al. Classification of isolated tumour cells and micrometastasis. Cancer. 1999;86:2668-2673.
25. Jamieson GG, Thompson SK. The detection of lymph node metastases in oesophageal cancer. Br J Surg. 2009;96:21-25.
26. Cserni G, Bianchi S, Vezzosi V, et al. Variations in sentinel node isolated tumour cells/micrometastasis and non-sentinel node involvement rates according to different interpretations of the TNM definitions. Eur J Cancer. 2008;44:2185-2191.
27. Cserni G, Bianchi S, Boecker W, et al. Improving the reproducibility of diagnosing micrometastases and isolated tumor cells. Cancer. 2005;103:358-367.
28. Cserni G. Isolated tumour cells versus micrometastases and non-sentinel node involvement in breast cancer. Eur J Surg Oncol. 2009;35:897-898.
29. De Mascarel I, MacGrogan G, Debled M, et al. Distinction between isolated tumor cells and micrometastases in breast cancer: is it reliable and useful? Cancer. 2008;112:1672-1678.
30. Turner RR, Weaver DL, Cserni G, et al. Nodal stage classification for breast carcinoma: improving interobserver reproducibility through standardized his-tologic criteria and image-based training. J Clin Oncol. 2008;26:258-263.
31. Horstmann O, Fuzesi L, Markus PM, et al. Significance of isolated tumor cells in lymph nodes among gastric cancer patients. J Cancer Res Clin Oncol. 2004;130:733-740.
32. Scheunemann P, Stoecklein NH, Hermann K, et al. Occult disseminated tumor cells in lymph nodes of patients with gastric carcinoma: a critical appraisal of assessment and relevance. Langenbecks Arch Surg. 2009;394: 105-113.
33. Scheri RP, Essner R, Turner RR, et al. Isolated tumor cells in the sentinel lymph node affect long-term prognosis of patients with melanoma. Ann Surg Oncol. 2007;14:2861-2866.
34. Mittendorf EA, Sahin AA, Tucker SL, et al. Lymphovascular invasion and lobular histology are associated with increased incidence of isolated tumor cells in sentinel lymph nodes from early-stage breast cancer patients. Ann Surg Oncol. 2008;15:3369-3377.
35. Ryden L, Chebil G, Sjostrom L, et al. Determination of sentinel lymph node (SLN) status in primary breast cancer by prospective use of immu-nohistochemistry increases the rate of micrometastases and isolated tumour cells: analysis of 174 patients after SLN biopsy. Eur J Surg Oncol. 2007;33:33-38.
36. Li J, Rudas M, Kemmner W, et al. The location of small tumor deposits in the SLN predicts non-SLN macrometastases in breast cancer patients. Eur J Surg Oncol. 2008;34:857-862.
37. Bukholm IR, Bondi J, Wiik P, et al. Presence of isolated tumour cells in mesenteric lymph nodes predicts poor prognosis in patients with stage II colon cancer. Eur J Surg Oncol. 2003;29:862-866.
38. Mescoli C, Rugge M, Pucciarelli S, et al. High prevalence of isolated tumour cells in regional lymph nodes from pN0 colorectal cancer. J Clin Pathol. 2006;59:870-874.
39. Rosenburg R, Friederichs J, Gertler R, et al. Prognostic evaluation and review of immunohistochemically detected disseminated tumor cells in peritumoral lymph nodes of patients with pN0 colorectal cancer. Int J Colorectal Dis. 2004;19:430-437.
40. Passlick B, Izbicki JR, Kubuschok B, et al. Immunohistochemical assessment of individual tumor cells in lymph nodes of patients with non-small-cell lung cancer. J Clin Oncol. 1994;12:1827-1832.
41. van Akkooi AC, de Wilt JH, Verhoef C, et al. Isolated tumor cells and long-term prognosis of patients with melanoma. Ann Surg Oncol. 2008;15: 1547-1548.
42. Viale G, Dell'Orto P, Biasi MO, et al. Comparative evaluation of an extensive histopathologic examination and a real-time reverse-transcription- polymerase chain reaction assay for mammaglobin and cytokeratin 19 on axillary sentinel lymph nodes of breast carcinoma patients. Ann Surg. 2008;247:136-142.
43. Murali R, Thompson JF, Shaw HM, et al. The prognostic significance of isolated immunohistochemically positive cells in sentinel lymph nodes of melanoma patients. Am J Surg Pathol. 2008;32:1106-1107.
44. Lamb PJ, Griffin SM, Burt AD, et al. Sentinel node biopsy to evaluate the metastatic dissemination of esophageal adenocarcinoma. Br J Surg. 2005;92: 60-67.
45. Kitagawa Y, Fujii H, Mukai M, et al. Sentinel lymph node mapping in esophageal and gastric cancer. Cancer Treat Res. 2005;127:123-139.
46. Setoyama T, Natsugoe S, Okumura H, et al. Isolated tumour cells in blood and E-cadherin expression in oesophageal squamous cell cancer. Br J Surg. 2007;94:984-991.
47. Koyanagi K, Bilchik AJ, Saha S, et al. Prognostic relevance of occult nodal micrometastases and circulating tumor cells in colorectal cancer in a prospective multicenter trial. Clin Cancer Res. 2008;14:7391-7396.
48. McGrath S, Cross S, Pritchard SA. Histopathological assessment of lymph nodes in upper gastrointestinal cancer: does triple leveling detect significantly more metastases? J Clin Pathol. 2007;60:1222-1225.
49. Viale G, Bosari S, Mazzarol G, et al. Intraoperative examination of axillary sentinel lymph nodes in breast carcinoma patients. Cancer. 1999;85:2433-2438.
50. Turner RR, Ollila DW, Stern S, et al. Optimal histopathologic examination of the sentinel lymph node for breast carcinoma staging. Am J Surg Pathol. 1999;23:263-267. (Pubitemid 29117560)